Brain heparanase expression is up-regulated during postnatal development and hypoxia-induced neovascularization in adult rats

Journal of Neurochemistry

Volumn 105, Issue 1, 2008, Pages 34-45

  Navarro, Fabrice P ^a,b,c,d,e   Fares, Raafat P ^a,b,c,d,e   Sanchez, Pascal E ^a,b,c,d,e   Nadam, Jérémie ^a,b,c,d,e   Georges, Béatrice ^a,b,c,d,e   Moulin, Colette ^a,b,c,d,e   Morales, Anne ^a,b,c,d,e   Pequignot, Jean Marc ^a,b,c,d,e   Bezin, Laurent ^a,b,c,d,e  

^a UNIVERSITÉ DE LYON   (France)

^b Institut Fédératif de Recherche 41   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

^e CNRS   (France)

Author keywords

Angiogenesis; Environmental enrichment; Hippocampus; Neocortex; Neuronal differentiation; Vascular endothelial growth factor

Indexed keywords

HEPARANASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HISTOLOGY; HYPOXIA; IMMUNOBLOTTING; IN VITRO STUDY; MALE; NEOCORTEX; NEOVASCULARIZATION (PATHOLOGY); NERVE CELL PLASTICITY; NERVE FIBER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANOXIA; ANTIGENS, CD34; BRAIN; BROMODEOXYURIDINE; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; ENVIRONMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUCURONIDASE; ISCHEMIC PRECONDITIONING; MALE; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTOR; PC12 CELLS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

RATTUS;

EID: 41149127677     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.05116.x     Document Type: Article

References (72)

1. Bayer S. A., Altman J., Russo R. J. Zhang X. (1993) Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 14, 83 144.
2. Bernaudin M., Nedelec A. S., Divoux D., MacKenzie E. T., Petit E. Schumann-Bard P. (2002) Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J. Cereb. Blood Flow Metab. 22, 393 403.
3. Bovolenta P. Marti E. (2005) Introduction: unexpected roles for morphogens in the development and regeneration of the CNS. J. Neurobiol. 64, 321 323.
4. Cao L., Jiao X., Zuzga D. S., Liu Y., Fong D. M., Young D. During M. J. (2004) VEGF links hippocampal activity with neurogenesis, learning and memory. Nat. Genet. 36, 827 835.
5. Chavez J. C., Agani F., Pichiule P. LaManna J. C. (2000) Expression of hypoxia-inducible factor-1alpha in the brain of rats during chronic hypoxia. J. Appl. Physiol. 89, 1937 1942.
6. Deepa S. S., Yamada S., Zako M., Goldberger O. Sugahara K. (2004) Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. A novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor. J. Biol. Chem. 279, 37368 37376.
7. Dong J., Kukula A. K., Toyoshima M. Nakajima M. (2000) Genomic organization and chromosome localization of the newly identified human heparanase gene. Gene 253, 171 178.
8. Duncan G., McCormick C. Tufaro F. (2001) The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins. J. Clin. Invest. 108, 511 516.
9. Esko J. D. Selleck S. B. (2002) Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71, 435 471.
10. Ethell I. M., Irie F., Kalo M. S., Couchman J. R., Pasquale E. B. Yamaguchi Y. (2001) EphB/syndecan-2 signaling in dendritic spine morphogenesis. Neuron 31, 1001 1013.
11. Fairbanks M. B., Mildner A. M., Leone J. W. et al. (1999) Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer. J. Biol. Chem. 274, 29587 29590.
12. Gallagher J. T. (2001) Heparan sulfate: growth control with a restricted sequence menu. J. Clin. Invest. 108, 357 361.
13. Gingis-Velitski S., Zetser A., Kaplan V. et al. (2004) Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans. J. Biol. Chem. 279, 44084 44092.
14. Goldshmidt O., Zcharia E., Aingorn H., Guatta-Rangini Z., Atzmon R., Michal I., Pecker I., Mitrani E. Vlodavsky I. (2001) Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence. J. Biol. Chem. 276, 29178 29187.
15. Goldshmidt O., Zcharia E., Cohen M., Aingorn H., Cohen I., Nadav L., Katz B. Z., Geiger B. Vlodavsky I. (2003) Heparanase mediates cell adhesion independent of its enzymatic activity. FASEB J. 17, 1015 1025.
16. Greenberg D. A. Jin K. (2005) From angiogenesis to neuropathology. Nature 438, 954 959.
17. Hickmott P. W. Ethell I. M. (2006) Dendritic plasticity in the adult neocortex. Neuroscientist 12, 16 28.
18. Hulett M. D., Freeman C., Hamdorf B. J., Baker R. T., Harris M. J. Parish C. R. (1999) Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat. Med. 5, 803 809.
19. Inatani M. Yamaguchi Y. (2003) Gene expression of EXT1 and EXT2 during mouse brain development. Brain Res. Dev. Brain Res. 141, 129 136.
20. Ishai-Michaeli R., Eldor A. Vlodavsky I. (1990) Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regul. 1, 833 842.
21. Kobayashi M., Naomoto Y., Nobuhisa T. et al. (2006) Heparanase regulates esophageal keratinocyte differentiation through nuclear translocation and heparan sulfate cleavage. Differentiation 74, 235 243.
22. Kussie P. H., Hulmes J. D., Ludwig D. L., Patel S., Navarro E. C., Seddon A. P., Giorgio N. A. Bohlen P. (1999) Cloning and functional expression of a human heparanase gene. Biochem. Biophys. Res. Commun. 261, 183 187.
23. Lander A. D. (1993) Proteoglycans in the nervous system. Curr. Opin. Neurobiol. 3, 716 723.
24. Levy-Adam F., Miao H. Q., Heinrikson R. L., Vlodavsky I. Ilan N. (2003) Heterodimer formation is essential for heparanase enzymatic activity. Biochem. Biophys. Res. Commun. 308, 885 891.
25. Lin X. (2004) Functions of heparan sulfate proteoglycans in cell signaling during development. Development 131, 6009 6021.
26. Lin X., Buff E. M., Perrimon N. Michelson A. M. (1999) Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development 126, 3715 3723.
27. Lindahl U., Kusche-Gullberg M. Kjellen L. (1998) Regulated diversity of heparan sulfate. J. Biol. Chem. 273, 24979 24982.
28. Lortat-Jacob H., Grosdidier A. Imberty A. (2002) Structural diversity of heparan sulfate binding domains in chemokines. Proc. Natl Acad. Sci. USA 99, 1229 1234.
29. Luhmann H. J., Hanganu I. Kilb W. (2003) Cellular physiology of the neonatal rat cerebral cortex. Brain Res. Bull. 60, 345 353.
30. Lyon M. Gallagher J. T. (1998) Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion. Matrix Biol. 17, 485 493.
31. Marchetti D. Nicolson G. L. (2001) Human heparanase: a molecular determinant of brain metastasis. Adv. Enzyme Regul. 41, 343 359.
32. Marchetti D., Li J. Shen R. (2000) Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase. Cancer Res. 60, 4767 4770.
33. Margolis R. K. Margolis R. U. (1993) Nervous tissue proteoglycans. Experientia 49, 429 446.
34. McKenzie E., Young K., Hircock M. et al. (2003) Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells. Biochem. J. 373, 423 435.
35. Miao H. Q., Navarro E., Patel S. et al. (2002) Cloning, expression, and purification of mouse heparanase. Protein Expr. Purif. 26, 425 431.
36. Ming G. L. Song H. (2005) Adult neurogenesis in the mammalian central nervous system. Annu. Rev. Neurosci. 28, 223 250.
37. Miyamoto O., Sumitani K., Takahashi M., Hirakawa H., Kusakabe T., Hayashida Y. Itano T. (2005) Vascular changes in the rat brain during chronic hypoxia in the presence and absence of hypercapnia. Acta Med. Okayama 59, 135 143.
38. Moretti M., Sinnappah-Kang N. D., Toller M., Curcio F. Marchetti D. (2006) HPSE-1 expression and functionality in differentiating neural cells. J. Neurosci. Res. 83, 694 701.
39. Nadam J., Navarro F., Sanchez P. et al. (2007) Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus. Neurobiol. Dis. 25, 412 426.
40. Nakajima M., Irimura T. Nicolson G. L. (1988) Heparanases and tumor metastasis. J. Cell. Biochem. 36, 157 167.
41. Nardella C., Lahm A., Pallaoro M., Brunetti M., Vannini A. Steinkuhler C. (2004) Mechanism of activation of human heparanase investigated by protein engineering. Biochemistry 43, 1862 1873.
42. Nasser N. J., Nevo E., Shafat I., Ilan N., Vlodavsky I. Avivi A. (2005) Adaptive evolution of heparanase in hypoxia-tolerant Spalax: gene cloning and identification of a unique splice variant. Proc. Natl Acad. Sci. USA 102, 15161 15166.
43. Nithianantharajah J. Hannan A. J. (2006) Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat. Rev. Neurosci. 7, 697 709.
44. Nobuhisa T., Naomoto Y., Okawa T. et al. (2007) Translocation of heparanase into nucleus results in cell differentiation. Cancer Sci. 98, 535 540.
45. Okada Y., Yamada S., Toyoshima M., Dong J., Nakajima M. Sugahara K. (2002) Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis. Hierarchical sulfate groups with different effects and the essential target disulfated trisaccharide sequence. J. Biol. Chem. 277, 42488 42495.
46. Ornitz D. M. Leder P. (1992) Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J. Biol. Chem. 267, 16305 16311.
47. Parish C. R. (2006) The role of heparan sulphate in inflammation. Nat. Rev. Immunol. 6, 633 643.
48. Parish C. R., Coombe D. R., Jakobsen K. B., Bennett F. A. Underwood P. A. (1987) Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanases. Int. J. Cancer 40, 511 518.
49. Parish C. R., Freeman C. Hulett M. D. (2001) Heparanase: a key enzyme involved in cell invasion. Biochim. Biophys. Acta 1471, M99 M108.
50. Patt S., Sampaolo S., Theallier-Janko A., Tschairkin I. Cervos-Navarro J. (1997) Cerebral angiogenesis triggered by severe chronic hypoxia displays regional differences. J. Cereb. Blood Flow Metab. 17, 801 806.
51. Perrimon N. Bernfield M. (2000) Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404, 725 728.
52. Pikas D. S., Li J. P., Vlodavsky I. Lindahl U. (1998) Substrate specificity of heparanases from human hepatoma and platelets. J. Biol. Chem. 273, 18770 18777.
53. Plate K. H. (1999) Mechanisms of angiogenesis in the brain. J. Neuropathol. Exp. Neurol. 58, 313 320.
54. Plate K. H., Breier G., Weich H. A. Risau W. (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359, 845 848.
55. van Praag H., Kempermann G. Gage F. H. (2000) Neural consequences of environmental enrichment. Nat. Rev. Neurosci. 1, 191 198.
56. Rapraeger A. C. (1995) In the clutches of proteoglycans: how does heparan sulfate regulate FGF binding? Chem. Biol. 2, 645 649.
57. Rapraeger A. C., Krufka A. Olwin B. B. (1991) Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252, 1705 1708.
58. Reuss B. von Bohlen und Halbach O. (2003) Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res. 313, 139 157.
59. Sotnikov I., Hershkoviz R., Grabovsky V., Ilan N., Cahalon L., Vlodavsky I., Alon R. Lider O. (2004) Enzymatically quiescent heparanase augments T cell interactions with VCAM-1 and extracellular matrix components under versatile dynamic contexts. J. Immunol. 172, 5185 5193.
60. Stranahan A. M., Khalil D. Gould E. (2006) Social isolation delays the positive effects of running on adult neurogenesis. Nat. Neurosci. 9, 526 533.
61. Taipale J. Keski-Oja J. (1997) Growth factors in the extracellular matrix. FASEB J. 11, 51 59.
62. Thunberg L., Backstrom G., Wasteson A., Robinson H. C., Ogren S. Lindahl U. (1982) Enzymatic depolymerization of heparin-related polysaccharides. Substrate specificities of mouse mastocytoma and human platelet endo-beta-D-glucuronidases. J. Biol. Chem. 257, 10278 10282.
63. Toyoshima M. Nakajima M. (1999) Human heparanase. Purification, characterization, cloning, and expression. J. Biol. Chem. 274, 24153 24160.
64. Turnbull J., Powell A. Guimond S. (2001) Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol. 11, 75 82.
65. Vaquero J., Zurita M., Coca S., Oya S. Morales C. (2000) Prognostic significance of clinical and angiogenesis-related factors in low-grade oligodendrogliomas. Surg. Neurol. 54, 229 234 discussion 234.
66. Vlodavsky I., Friedmann Y., Elkin M. et al. (1999) Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat. Med. 5, 793 802.
67. Yabe T., Hata T., He J. Maeda N. (2005) Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain. Glycobiology 15, 982 993.
68. Yamaguchi Y. (2001) Heparan sulfate proteoglycans in the nervous system: their diverse roles in neurogenesis, axon guidance, and synaptogenesis. Semin. Cell Dev. Biol. 12, 99 106.
69. Yayon A., Klagsbrun M., Esko J. D., Leder P. Ornitz D. M. (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841 848.
70. Young P. E., Baumhueter S. Lasky L. A. (1995) The sialomucin CD34 is expressed on hematopoietic cells and blood vessels during murine development. Blood 85, 96 105.
71. Zetser A., Bashenko Y., Edovitsky E., Levy-Adam F., Vlodavsky I. Ilan N. (2006) Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res. 66, 1455 1463.
72. Zhang Y., Yeung M. N., Liu J., Chau C. H., Chan Y. S. Shum D. K. (2006) Mapping heparanase expression in the spinal cord of adult rats. J. Comp. Neurol. 494, 345 357.